The company’s valuation had dropped from $6 billion in 2021, to under $150 million after going public and when CEO Anne Wojcicki pushed for a plan to buy it and take it private, the board rejected her ...
A spokesperson for 23andMe would not comment to NPR on what will happen to genetic data, except to express the company’s ...
Financial and security chaos at the once-pioneering genetic testing firm has intensified concerns about user data. Here's how ...
In 2009, Anne Wojcicki took a decisive step in her role as the leader of 23andMe, the genetic testing company she co-founded ...
Amazon Fire 7 tablet (16GB): was $79.99 now $49.99 at Amazon Amazon's best-selling Fire tablets are another Black Friday ...
Anne Wojcicki, the CEO of the consumer genetic testing company 23andMe (ME), is cautiously optimistic about the firm’s future ...
A huge data breach followed by a plummeting valuation has stoked fears of a sale of 23andMe along with all of its customers' genetic data.
Since it was founded nearly two decades ago, 23andMe has grown into one of the largest biotechnology companies in the world.
Anne Wojcicki, CEO of 23andMe, the struggling DNA testing company, doesn’t think this is the right time to examine her ...
New research has found that genetics, not lifestyle, is the primary cause of gout. The study identified key genes and immune ...
Gray’s optimism on IPO markets provided a positive gloss to its muted asset sales in third-quarter results released on Thursday. The biggest story at Blackstone is its continued growth in almost any ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback